Previous studies have found that exogenous FGF21 administration can exhibit great metabolic effects on HFD obese mice 170, and FGF21 deficiency will aggravate obesity-induced inflammation and inflammation-mediated atrophy in obese mouse skeletal muscle 171. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.